Heterograft Cardiac Valve Prostheses: A Five-Year Follow-up

The major advance in the management of valvular heart disease over the past twenty years has been due to prosthetic valve operation. The bioprostheses have good hemodynamic function and a low rate of thromboembolism although the long-term durability is unknown. In this series of 25 patients with 27...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Annals of thoracic surgery 1980-08, Vol.30 (2), p.173-176
Hauptverfasser: Grehl, Todd M., Naifeh, Jerome G., Broda, John, Dajee, Amrit, Hurley, Edward J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The major advance in the management of valvular heart disease over the past twenty years has been due to prosthetic valve operation. The bioprostheses have good hemodynamic function and a low rate of thromboembolism although the long-term durability is unknown. In this series of 25 patients with 27 valves implanted over five years, there was an 8% early mortality and a 12% late mortality. There have been no thromboembolic episodes. Primary valvular dysfunction requiring operation occurred in 7.4% (2 out of 27). All surviving patients are in New York Heart Association Functional Class I or II.
ISSN:0003-4975
1552-6259
DOI:10.1016/S0003-4975(10)61237-4